Article Information
History
- August 28, 2023.
Article Versions
- Version 1 (March 21, 2023 - 19:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Ksenija Nesic1,2,#,
- John J. Krais3,#,
- Cassandra J. Vandenberg1,2,
- Yifan Wang3,
- Pooja Patel3,
- Kathy Q. Cai3,
- Tanya Kwan4,
- Elizabeth Lieschke1,2,
- Gwo-Yaw Ho5,
- Holly E. Barker1,2,
- Justin Bedo1,2,
- Silvia Casadei6,
- Andrew Farrell1,2,
- Marc Radke6,
- Kristy Shield-Artin1,2,
- Jocelyn S. Penington1,2,
- Franziska Geissler1,2,
- Elizabeth Kyran1,2,
- Fan Zhang7,
- Alexander Dobrovic7,
- Inger Olesen8,
- Rebecca Kristeleit9,10,
- Amit Oza11,
- Gayanie Ratnayake12,
- Nadia Traficante13,14,
- Australian Ovarian Cancer Study,
- Anna DeFazio15,16,17,
- David D. L. Bowtell13,14,
- Thomas C. Harding4,
- Kevin Lin4,
- Elizabeth M. Swisher6,
- Olga Kondrashova18,
- Clare L. Scott1,2,12,13,14,19,*,
- Neil Johnson3,!,* and
- Matthew J. Wakefield1,2,19,*
- 1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- 2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
- 3Fox Chase Cancer Center, PA, USA
- 4Clovis Oncology Inc., San Francisco, CA, USA
- 5School of Clinical Sciences, Monash University, Clayton, Victoria, Australia
- 6University of Washington, Seattle, WA, USA
- 7University of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia
- 8The Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia
- 9Department of Oncology, Guys and St Thomas’ NHS Foundation Trust, London, UK
- 10National Institute for Health Research, University College London Hospitals Clinical Research Facility, London, UK
- 11Princess Margaret Cancer Center, Toronto, ON, Canada
- 12Royal Women’s Hospital, Parkville, VIC, Australia
- 13Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- 14Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
- 15The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, New South Wales, Australia
- 16The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
- 17Department of Gynecological Oncology, Westmead Hospital, Western Sydney Local Health District, New South Wales, Australia
- 18QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
- 19Department of Obstetrics and Gynecology, University of Melbourne, Parkville, VIC, Australia
- ↵!Corresponding authors:
Neil Johnson, Fox Chase Cancer Center, PA, USA (Email: Neil.Johnson{at}fccc.edu) Clare L Scott, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. (Email: scottc{at}wehi.edu.au)
Posted August 28, 2023.
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
